-
Dabigatran, sold
under the
brand name
Pradaxa among others, is an
anticoagulant used to
treat and
prevent blood clots and to
prevent stroke in
people with...
- US FDA in 2015, that
reverses the
effect of
dabigatran by
binding to both free and thrombin-bound
dabigatran.
Andexanet alfa is a
recombinant modified human...
-
Unfractionated heparin (w/ warfarin) LMWH/Low
molecular weight heparin Dabigatran Direct Factor Xa
Inhibitors Graduated compressed stocking High degree...
- (pramipexole) Ofev /
Vargatef (Nintedanib)
Mobic /
Movalis (meloxicam)
Pradaxa (
dabigatran etexilate)
Spiriva (tiotropium bromide)
Trajenta /
Tradjenta (linagliptin)...
- name Praxbind, is a
monoclonal antibody used as a
reversal agent for
dabigatran.
Idarucizumab was
developed by
Boehringer Ingelheim. One
study sponsored...
-
Other drugs with
adverse reactions include dabigatran etexilate, lamivudine, and vincristine.
Dabigatran etexilate used with p-glycoprotein inducers...
-
treatment used. Oral anticoagulants,
especially Xa (apixaban) and
thrombin (
dabigatran) inhibitors, have been
shown to be
superior to
warfarin in
stroke reduction...
-
already in
clinical use (such as lepirudin, argatroban,
bivalirudin and
dabigatran). Also in
clinical use are
other small molecular compounds that interfere...
- INR of 2-3) or one of the
direct oral
anticoagulant drugs (DOACs, e.g.
dabigatran, rivaroxaban, edoxaban, or apixaban) is recommended. If the
patient is...
- treatment,
whereas dabigatran and
edoxaban do. A
Cochrane review found that
there is no
evidence of a
difference between oral DTIs (
dabigatran, rivaroxaban...
